DAX25.261 +0,9%Est506.131 +1,2%MSCI World4.343 -0,1%Top 10 Crypto8,3200 -3,8%Nas22.886 +0,9%Bitcoin54.612 -4,5%Euro1,1758 -0,1%Öl71,26 -0,6%Gold5.171 +1,3%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Rheinmetall 703000 SAP 716460 Bayer BAY001 Microsoft 870747 Infineon 623100 Siemens Energy ENER6Y Amazon 906866 Deutsche Telekom 555750 Allianz 840400 Lufthansa 823212 Novo Nordisk A3EU6F BASF BASF11 Siemens 723610 Mercedes-Benz Group (ex Daimler) 710000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX und Wall Street gehen stärker ins Wochenende -- Supreme Court stoppt Trump-Zölle -- NVIDIA wohl mit Milliardeninvestment in OpenAI -- Apple, Telekom, BioNTech, Moderna, Diginex, Bayer im Fokus
Top News
Der Architekt der Multi-Industrie-Revolution: Elon Musk führt die Forbes-Innovatoren-Liste an - Tesla-Aktie, SpaceX & Co. Der Architekt der Multi-Industrie-Revolution: Elon Musk führt die Forbes-Innovatoren-Liste an - Tesla-Aktie, SpaceX & Co.
Radikaler Umbau im Depot: NVIDIA verkauft Beteiligungen - Neue Aktie an der Spitze Radikaler Umbau im Depot: NVIDIA verkauft Beteiligungen - Neue Aktie an der Spitze
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

NetraMark Aktie

Kaufen
Verkaufen
0,6300 EUR -0,0250 EUR -3,82 %
BMN
1,07 CAD ±0,00 CAD ±0,00 %
TSX
NetraMark jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.61,01 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA3D5X9

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINCA64119M1059

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolAINMF

NetraMark Aktien News

DatumMeistgelesen
PR NewswireNETRAMARK TO HOST SHAREHOLDER CONFERENCE CALL TO DISCUSS BUSINESS MOMENTUM
PR NewswireNETRAMARK TO HOST SHAREHOLDER CONFERENCE CALL TO DISCUSS BUSINESS MOMENTUM
PR NewswireNETRAMARK AND WORLDWIDE CLINICAL TRIALS ANNOUNCE AGREEMENT TO TRANSFORM CLINICAL TRIAL DESIGN WITH AI-POWERED PRECISION
Wer­bungNetraMark-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireNETRAMARK AND WORLDWIDE CLINICAL TRIALS ANNOUNCE AGREEMENT TO TRANSFORM CLINICAL TRIAL DESIGN WITH AI-POWERED PRECISION
PR NewswireNETRAMARK STRENGTHENS FINANCIAL POSITION WITH ADDITIONAL $1,853,054 RAISED FROM WARRANT EXERCISE
PR NewswireNETRAMARK UNVEILS AI DRIVEN INSIGHTS FOR MAJOR DEPRESSIVE DISORDER AND SCHIZOPHRENIA AT ISCTM CONFERENCE
PR NewswireNETRAMARK AND THE ONTARIO BRAIN INSTITUTE PARTNER TO ADVANCE AI-POWERED NEUROANALYTICS FOR MAJOR DEPRESSION RESEARCH
PR NewswireNETRAMARK TO PRESENT NOVEL AI-BASED CLINICAL TRIAL TREATMENT SEPARATION TOOLS AT ISCTM ANNUAL MEETING
PR NewswireNETRAMARK TO PRESENT NOVEL AI-BASED CLINICAL TRIAL TREATMENT SEPARATION TOOLS AT ISCTM ANNUAL MEETING
PR NewswireNETRAMARK LAUNCHES NETRAAI 2.0: ADVANCING CLINICAL TRIAL ANALYSIS WITH AI-POWERED INSIGHTS
PR NewswireNETRAMARK PROVIDES BUSINESS UPDATE
PR NewswireNETRAMARK STRENGTHENS FINANCIAL POSITION WITH $1,161,000 RAISED FROM WARRANT AND STOCK OPTION EXERCISE
PR NewswireNETRAMARK EXPANDS TEAM WITH THE ADDITION OF INDUSTRY VETERAN
PR NewswireNETRAMARK SIGNS A PILOT COLLABORATION AGREEMENT WITH A TOP 5 PHARMACEUTICAL COMPANY
PR NewswireONCOLOGY COMMERCIALIZATION LEADER P.J. HALEY TO JOIN NETRAMARK BOARD OF DIRECTORS
PR NewswireNETRAMARK EXPANDS PRODUCT OFFERINGS TO ADDRESS CORE CLINICAL TRIAL CHALLENGES AND IMPROVE MARKET ACCESS SUCCESS
PR NewswireNETRAMARK PROVIDES Q3 BUSINESS UPDATE AND HIGHLIGHTS PROGRESS
PR NewswireNETRAMARK ANNOUNCES COLLABORATION AGREEMENT WITH NIMH TO ANALYZE CLINICAL TRIAL DATA ON THE USE OF KETAMINE IN PSYCHIATRIC DISORDERS
PR NewswireNETRAMARK TO INTRODUCE THE TREATMENT ATTITUDE PROFILE (TAP™) SCALE FOR PLACEBO RESPONSE PERSONA DISCOVERY USING ITS NETRA AI TECHNOLOGY AT THE 2024 ASCP ANNUAL MEETING
PR NewswireNETRAMARK'S AI-BASED CLINICAL SOLUTION IDENTIFIES NOVEL LUNG AND COLON CANCER BIOMARKERS AND PATIENT SUBPOPULATIONS
PR NewswireNETRAMARK ANNOUNCES SHAREHOLDER MEETING RESULTS
PR NewswirePHARMACEUTICAL INDUSTRY VETERAN JOINS NETRAMARK ADVISORY BOARD
PR NewswireNETRAMARK PROVIDES BUSINESS UPDATE AND HIGHLIGHTS PROGRESS
PR NewswireNETRAMARK SIGNS CONTRACT WITH PHARMACEUTICAL COMPANY TO DELIVER CLINICAL TRIAL INSIGHTS REGARDING EFFICACY AND PLACEBO RESPONSE
PR NewswireNETRAMARK'S AI-BASED CLINICAL SOLUTION IDENTIFIES PARKINSON'S DISEASE SUBTYPES LINKED BY MITOCHONDRIAL, MICROBIOME AND IMMUNE SIGNALING
PR NewswireNETRAMARK TO PRESENT NEW DATA HIGHLIGHTING THE UTILITY OF IT'S AI-BASED CLINICAL SOLUTION IN IDENTIFYING PARKINSON'S DISEASE ASSOCIATED BIOMARKERS AT AD/PD™ 2024
PR NewswireNETRAMARK SIGNS FOURTH CONTRACT WITH LARGE BIOPHARMACEUTICAL COMPANY TO ENHANCE CLINICAL TRIAL INSIGHTS
PR NewswireNETRAMARK'S AI-BASED TECHNOLOGY IDENTIFIES SIGNIFICANT DRIVERS OF EFFICACY AND PLACEBO RESPONSES AND HAS POTENTIAL TO IMPROVE SUCCESS RATES FOR CLINICAL TRIALS OF PSYCHIATRIC MEDICATIONS
PR NewswireNETRAMARK TO PRESENT NEW DATA DEMONSTRATING THE POWER OF ITS AI BASED TECHNOLOGY TO DE-RISK NEUROLOGY CLINICAL TRIALS AT ISCTM ANNUAL MEETING
PR NewswireNETRAMARK ANNOUNCES LAUNCH OF THE NETRA AI LAB
PR NewswireNETRAMARK SIGNS THIRD CONTRACT WITH LARGE BIOPHARMACEUTICAL COMPANY TO ENHANCE CLINICAL TRIAL INSIGHTS
PR NewswireNetraMark's Generative AI Discovers Novel Rare Disease Drug Targets and Unique Patient Subpopulations That Could Substantially Improve Clinical Trial Success Rates
PR NewswireNETRAMARK SIGNS TWO CONTRACTS WITH LARGE BIOPHARMACEUTICAL COMPANY TO ENHANCE CLINICAL TRIAL INSIGHTS
PR NewswireNETRAMARK SELECTS FINN PARTNERS AS ITS PUBLIC RELATIONS AGENCY OF RECORD
PR NewswirePHARMACEUTICAL INDUSTRY VETERAN JOINS NETRAMARK AS CHIEF MEDICAL OFFICER
PR NewswireNETRAMARK SIGNS MASTER SERVICE AGREEMENT WITH A LARGE BIOPHARMACEUTICAL COMPANY
PR NewswireNETRAMARK PRIVATE PLACEMENT - PRESS RELEASE CLARIFICATION
PR NewswireNETRAMARK ANNOUNCES PRIVATE PLACEMENT FINANCING
PR NewswirePHARMACEUTICAL INDUSTRY VETERAN JOINS NETRAMARK ADVISORY BOARD
PR NewswireNETRAMARK ANNOUNCES SHARES FOR DEBT SETTLEMENT

NetraMark News

NetraMark News: auf dieser Seite finden Sie alle NetraMark News und Nachrichten zur NetraMark Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch NetraMark News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um NetraMark News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.